Capping decades of research, a study in Cell Stem Cell may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely. Using cells donated by patients, researchers at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center identified several small molecules that appear to rebuild telomere and reverse this cellular aging process.
- Study suggests coffee temporarily counteracts effect of sleep loss on cognitive function
- Sloan Kettering Institute scientists solve a 100-year-old mystery about cancer
- Study says friends are most valued in cultures where they may be needed most
- Astronomers discover first cloudless, Jupiter-like planet
- Creating a safe CAR T-Cell therapy to fight solid tumors in children